|
Comparison
|
Outcome measures
|
|---|
|
ATTA
|
30-day mortality [%]
|
ICU-stay [days]
|
Hospital stay [days]
|
Low cardiac output [%]
|
|---|
|
CECC versus MECC
| | | | |
|
CECC (n=175)
|
14.8
|
5.3
|
13
|
11.4
|
|
MECC (n=146)
|
6.9
|
4.6
|
12
|
5.6
|
|
Unadjusted mean difference
|
−7.9
|
−0.8
|
−1
|
−5.8
|
|
p-value
|
0.03B
|
0.11
|
0.80
|
0.07B
|
|
Adjusted mean difference after matching of 100 pairs (95% bias corrected CI)
|
−1.0 (−8.6 to 7.6)
|
1.0 (−0.21 to 3.24)
|
1.0 (−2 to 3.6)
|
−1.1 (−7.3 to 7.1)
|
|
p-value
|
1.0C
|
0.70F
|
0.40F
|
0.83C
|
|
ATED
| | | | |
|
Adjusted mean difference with 95% bias corrected CI)
|
−1.5 (−8.1 to 5.8)E
|
0.61 (−0.7 to 2.2)E
|
0.34 (−2.5 to 2.6)E
|
−1.7 (−7.1 to 6.5)E
|
-
A – ATT Average treatment effect for the Treated.
-
B – Fisher’s exact test.
-
C – McNemar’s test.
-
D – ATE Average treatment effect.
-
E – The 95% bias corrected confidence interval does include a zero, or p > 0.05 for a two-tailed test.
-
F – Wilcoxon’s signed rank test.
